Clinical Trial Update: Vigabatrin for the Treatment of Cocaine Dependency [Phase 2, Phase 3]

View source ↗

Summary

The document reports Phase 2 and Phase 3 trials evaluating vigabatrin for cocaine use disorder, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine Use Disorder

Drugs mentioned

• Vigabatrin (Vigabatrin)

Snippet

Sponsor: Catalyst Pharmaceuticals, Inc. | Conditions: Cocaine Addiction, Cocaine Dependence | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-02-23